Pirfenidone Capsule
Product Images NDC 69097-940
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 69097-940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Pirfenidone 02)
Figure 2 (Pirfenidone 03)
Figure 3 (Pirfenidone 04)
Principal Display Panel (90 Capsules)
This is a listing for Pirfenidone capsules with 90 capsules in each bottle. Each capsule contains 267mg of the active ingredient, pirfenidone. The usual dosage information can be found in the package insert. The capsules should be stored at temperatures between 15° to 30°C (59° to 86°F) and kept out of reach of children. They are manufactured for Cipla USA, Inc. and manufactured by ScieGen Pharmaceuticals, Inc. This medication is available by prescription only.*
Principal Display Panel (270 Capsules)
This is a prescription medicine with the brand name Pirfenidone, manufactured by Cipla USA, Inc. Each capsule contains 267 mg of pirfenidone. It comes in a package of 270 capsules. The recommended dose and administration information can be found in the package insert. The medicine should be stored at a temperature range of 15° to 30°C (59° to 86°F) and kept away from the reach of children. The manufacturer is ScieGen Pharmaceuticals, Inc., and the label was last revised in April 2022.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.